The market for radiation oncology is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and expected to reach the market value of around US$ 11.0 Bn by 2027.
Radiation oncology is a medical specialty and an essential part of a multidisciplinary approach to cancer treatment. This technology uses radiation (X-rays, gamma rays, or electrons) to treat cancer.
Market Dynamics
The rising adoption of radiotherapy along with the increasing cases of cancer diseases across the globe is driving the market growth. According to Cancer Australia, in 2020, Australia has been diagnosed with 145,483 registered cancer cases, which is approximately 480 cases per 100,000 persons. New Zealand has registered 24,453 cancer cases in the year 2017 which is approximately 331 cases per 100,000 persons. The technological advancements in radiotherapy owing to the increasing investments and rising prevalence of cancer as well as increasing healthcare expenditure across the globe are supporting the demand for radiation oncology practices. Additionally, the increasing application of radiopharmaceuticals across cancer treatment is further bolstering the regional market value.
On the other side, lack of skilled radiotherapy professionals, inadequate radiation infrastructure, and adverse effects of radiotherapy are some of the factors restricting the market growth.
Segment Instance of Global Radiation Oncology Market
External Beam Radiation Therapy dominated the Global Radiation Oncology Market by application in 2019
By application, the external beam radiation therapy (EBRT) segment leading the market with maximum revenue share owing to its usage across varied major types of cancer. Some of the major applicability is into prostate cancer, breast cancer, lung cancer, head & neck cancer, and colorectal cancer among others.
North America dominated the global radiation oncology market
In 2019, North America dominated the market with maximum revenue share, and the region is also projected to maintain its dominance throughout the forecast period from 2020 to 2027. The increasing number of cancer cases along with the changing lifestyle and unhealthy eating habits are supporting the market growth. The advanced healthcare infrastructure along with the high paying population is contributing to the regional market value.
Asia Pacific is projected to exhibit fastest growth over the forecast period from 2020 to 2027
Asia Pacific along with its major developing economies projected to exhibit the fastest growth during the forecast period from 2020 to 2027. The rapidly increasing number of healthcare facilities along with the advanced infrastructure and professionals that can operate them is driving the regional market value. Another factor driving regional market value is increasing cases of cancer due to rapid urbanization and subsequently changing lifestyle.
Key Market Players
The players profiled in the report include Accuray Incorporated, C.R. BARD, INC. (BD), Curium Pharma, Elekta AB, Ion Beam, Applications (IBA), Isoray Medical, Mevion Medical Systems, Inc., Nordion Inc., NTP Radioisotopes SOC Ltd., Varian Medical Systems, Inc., Viewray Technologies, Inc., and others.
Market Segmentation
Market By Type
External Beam Radiation Therapy
- Linear Accelerators (LINAC)
- Compact Advanced Radiotherapy Systems
Proton Therapy
Cyclotron
Synchrotron
Internal Beam Radiation Therapy
- Brachytherapy
- Systemic Beam Radiation Therapy
Others
Market By Technology
External Beam Radiation Therapy
- Image-Guided Radiotherapy (IGRT)
- Intensity Modulated Radiotherapy (IMRT)
- Stereotactic Application
- Proton Beam Therapy
- 3D Conformal Radiotherapy (3D CRT)
- Volumetric Modulated Arc Therapy (VMAT)
Internal Beam Radiation Therapy
- Low-Dose Rate Brachytherapy
- High-Dose Rate Brachytherapy
Systemic Radiation Therapy
Market By Application
External Beam Radiation Therapy
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Other
Internal Radiation Therapy
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Cervical Cancer
- Penile Cancer
- Other
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Radiation Oncology
1.1. Definition and Scope
1.1.1. Definition of Radiation Oncology
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Radiation Oncology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Radiation Oncology Market By Type
1.2.3. Radiation Oncology Market By Technology
1.2.4. Radiation Oncology Market By Application
1.2.5. Radiation Oncology Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Radiation Oncology Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Radiation Oncology Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Radiation Oncology Market By Type
4.1. Introduction
4.2. Radiation Oncology Revenue By Type
4.2.1. Radiation Oncology Revenue (US$ Mn) and Forecast, By Type, 2016-2027
4.2.2. External Beam Radiation Therapy
4.2.2.1. External Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.1. Linear Accelerators (Linac)
4.2.2.1.1.1. Linear Accelerators (Linac) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.1.2. Compact Advanced Radiotherapy Systems
4.2.2.1.2.1. Compact Advanced Radiotherapy Systems Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Proton Therapy
4.2.3.1. Proton Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Cyclotron
4.2.4.1. Cyclotron Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Synchrotron
4.2.5.1. Synchrotron Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Internal Beam Radiation Therapy
4.2.6.1. Internal Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6.1.1. Brachytherapy
4.2.6.1.1.1. Brachytherapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6.1.2. Systemic Beam Radiation Therapy
4.2.6.1.2.1. Systemic Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6.1.3. Others
4.2.6.1.3.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Radiation Oncology Market Revenue By Technology
5.1. Introduction
5.2. Radiation Oncology Revenue (US$ Mn) By Technology
5.2.1. Radiation Oncology Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
5.2.2. External Beam Radiation Therapy
5.2.2.1. External Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.1. Image-Guided Radiotherapy (IGRT)
5.2.2.1.1.1. Image-Guided Radiotherapy (IGRT) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.2. Intensity Modulated Radiotherapy (IMRT)
5.2.2.1.2.1. Intensity Modulated Radiotherapy (IMRT) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.3. Stereotactic Technology
5.2.2.1.3.1. Stereotactic Technology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.4. Proton Beam Therapy
5.2.2.1.4.1. Proton Beam Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.5. 3D Conformal Radiotherapy (3D CRT)
5.2.2.1.5.1. 3D Conformal Radiotherapy (3D CRT) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.6. Volumetric Modulated Arc Therapy (VMAT)
5.2.2.1.6.1. Volumetric Modulated Arc Therapy (VMAT) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Internal Beam Radiation Therapy
5.2.3.1. Internal Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.1.1. Low-Dose Rate Brachytherapy
5.2.3.1.1.1. Low-Dose Rate Brachytherapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.1.2. High-Dose Rate Brachytherapy
5.2.3.1.2.1. High-Dose Rate Brachytherapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Systemic Radiation Therapy
5.2.4.1. Systemic Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Radiation Oncology Market By Application
6.1. Introduction
6.2. Radiation Oncology Revenue (US$ Mn) By Application
6.2.1. Radiation Oncology Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
6.2.2. External Beam Radiation Therapy
6.2.2.1. External Beam Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.1. Prostate Cancer
6.2.2.1.1.1. Prostate Cancer
6.2.2.1.2. Breast Cancer
6.2.2.1.2.1. Breast Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.3. Lung Cancer
6.2.2.1.3.1. Lung Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.4. Head & Neck Cancer
6.2.2.1.4.1. Head & Neck Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.5. Colorectal Cancer
6.2.2.1.5.1. Colorectal Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.6. Other
6.2.2.1.6.1. Other Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Internal Radiation Therapy
6.2.3.1. Internal Radiation Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.1. Others Prostate Cancer
6.2.3.1.1.1. Others Prostate Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.2. Gynecological Cancer
6.2.3.1.2.1. Gynecological Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.3. Breast Cancer
6.2.3.1.3.1. Breast Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.4. Cervical Cancer
6.2.3.1.4.1. Cervical Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.5. Penile Cancer
6.2.3.1.5.1. Penile Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.6. Others
6.2.3.1.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Radiation Oncology Market By Country
7.1. North America Radiation Oncology Overview
7.2. U.S.
7.2.1. U.S. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.2.2. U.S. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
7.2.3. U.S. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3. Canada
7.3.1. Canada Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.3.2. Canada Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
7.3.3. Canada Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Radiation Oncology Market By Country
8.1. Europe Radiation Oncology Market Overview
8.2. U.K.
8.2.1. U.K. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.K. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.2.3. U.K. Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Germany
8.3.1. Germany Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Germany Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.3.3. Germany Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. France
8.4.1. France Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.4.2. France Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.4.3. France Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5. Spain
8.5.1. Spain Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.5.2. Spain Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.5.3. Spain Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.6.2. Rest of Europe Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016-2027
8.6.3. Rest of Europe Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Radiation Oncology Market By Country
9.1. Asia Pacific Radiation Oncology Market Overview
9.2. China
9.2.1. China Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.2.2. China Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.2.3. China Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3. Japan
9.3.1. Japan Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.3.2. Japan Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.3.3. Japan Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4. India
9.4.1. India Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.4.2. India Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.4.3. India Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5. Australia
9.5.1. Australia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.5.2. Australia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.5.3. Australia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.6.2. South Korea Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.6.3. South Korea Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.7.2. Rest of Asia-Pacific Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
9.7.3. Rest of Asia-Pacific Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Radiation Oncology Market By Country
10.1. Latin America Radiation Oncology Market Overview
10.2. Brazil
10.2.1. Brazil Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. Brazil Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.2.3. Brazil Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Mexico Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.3.3. Mexico Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. Rest of Latin America Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
10.4.3. Rest of Latin America Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Radiation Oncology Market By Country
11.1. Middle East & Africa Radiation Oncology Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Saudi Arabia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.2.3. Saudi Arabia Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. UAE
11.3.1. UAE Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. UAE Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.3.3. UAE Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Radiation Oncology Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Middle East & Africa Radiation Oncology Market Revenue (US$ Mn) and Forecast By Technology, 2016 - 2027
11.4.3. Rest of Middle East & Africa Radiation Oncology Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Radiation Oncology
12.1. Radiation Oncology Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Radiation Oncology Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. Accuray Incorporated
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Accuray Incorporated 2019 Radiation Oncology Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. C.R. BARD, INC. (BD)
13.3. Curium Pharma
13.4. Elekta AB
13.5. Ion Beam Applications (IBA)
13.6. Isoray Medical
13.7. Mevion Medical Systems, Inc.
13.8. Nordion Inc.
13.9. NTP Radioisotopes SOC Ltd.
13.10. Varian Medical Systems, Inc.
13.11. Viewray Technologies, Inc.
13.12. Others
